Telecommunications Standard JULY 2012

Size: px
Start display at page:

Download "Telecommunications Standard JULY 2012"

Transcription

1 Telecommunications Standard

2 Telecommunications Standard Copyright 2012 National Council for Prescription Drug Programs, Inc. This work is owned by National Council for Prescription Drug Programs, Inc., 9240 E. Raintree Drive, Scottsdale, AZ 85260, (480) , and protected by the copyright laws of the United States. 17 U.S.C. 101, et. seq. Permission is given to Council members to copy and use the work or any part thereof in connection with the business purposes of the Council members. The work may not be changed or altered. The work may not be sold, used or exploited for commercial purposes. This permission may be revoked by National Council for Prescription Drug Programs, Inc., at any time. The National Council for Prescription Drugs Programs, Inc. is not responsible for any errors or damage as a result of the use of the work. NCPDP recognizes the confidentiality of certain information exchanged electronically through the use of its standards. Users should be familiar with the federal, state, and local laws, regulations and codes requiring confidentiality of this information and should utilize the standards accordingly. NOTICE: In addition, this NCPDP Standard contains certain data fields and elements that may be completed by users with the proprietary information of third parties. The use and distribution of third parties' proprietary information without such third parties' consent, or the execution of a license or other agreement with such third party, could subject the user to numerous legal claims. All users are encouraged to contact such third parties to determine whether such information is proprietary and if necessary, to consult with legal counsel to make arrangements for the use and distribution of such proprietary information.

3 TELECOMMUNICATIONS STANDARD Version n.n Table of Contents 3. BUSINESS ENVIRONMENT Objectives Participants Between Providers and Adjudicators... 2 iii

4

5 TELECOMMUNICATIONS STANDARD Version n.n 3 BUSINESS ENVIRONMENT 3.1 Objectives The NCPDP Telecommunication Standard Implementation Guide (Version D and above) is intended to meet two needs within the pharmacy drug claim industry: 1. to provide practical guidelines for software developers throughout the industry as they implement the Version D and above Standard, and 2. to ensure a consistent implementation of the Version D and above Standard. This version of the standard facilitates a specific type of business communication among diverse parties within the third party environment. To do this successfully, it must accomplish the following goals: Support the needs of a wide base of potential users, Maximize use of existing relevant standards wherever possible, Be flexible enough to change as needs and technology change, Be unambiguous, and Be easy to implement by carriers and vendors. 3.2 Participants The NCPDP Telecommunication Standard Implementation Guide (Version D and above) supports prescription claim transactions, services, and reportings between the following industry participants: Between Providers and Adjudicators, and Between Adjudicators (aka Payer-to-Payer) Between these entities and Switches/Intermediaries as determined by business need The NCPDP Telecommunication Standard Implementation Guide facilitates the exchange of information supporting REMS (Risk Evaluation & Mitigation Strategies) operations, PDMP (Prescription Drug Monitoring Program) reporting, and general communications between the following participants: Between Providers and REMS Administrators Between Providers and PDMP program administrators Between these entities and Switches and/or Intermediaries as determined by business need 1

6 Version n.n TELECOMMUNICATIONS STANDARD Between Providers and Adjudicators The communication between Providers and Adjudicators is two-way and the record layout for the transmitted claim and the response to the claim are defined by the Version D and above standard. The diagram below illustrates the typical business environments in which the NCPDP Telecommunication Standard Implementation Guide (Version D and above) is employed between providers and adjudicators. Figure Provider/Adjudicator Participants A Provider may be a retail pharmacy, mail order pharmacy, doctor s office, clinic, hospital, long-term care facility, or any other entity, which dispenses prescription drugs and submits those prescrip tions to a payer for reimbursement. A provider may be an entity that collects and reports information about prescribing, dispensing, and consumption of dangerous or abusable drugs or products such as a grocery store or convenience store. The Adjudicator (hereinafter referred to as the Processor ) is often a third-party administrator of prescription drug programs on behalf of insurers. The Adjudicator also may be an insurer, a governmental program or any other entity, which receives prescription drug claims, makes a decision regarding the level of reimbursement to the provider, and transmits a response to the provider. An adjudicator may be an entity that receives reporting information, record keeping, auditing, or authorizations of services, such as an entity performing drug utilization review reporting or reporting related to abusable products. 2

7 TELECOMMUNICATIONS STANDARD Version n.n Providers may choose to transmit certain prescription drug claims to an Intermediary. Intermediaries receive claims from switches or providers, perform editing/messaging and then either pass the claims to the appropriate switch or adjudicator or return (reject) claims to the providers. The reply from the adjudicator also may pass to an intermediary for editing and messaging on its return to the provider. Providers may choose to transmit claims to an intermediary for a number of reasons, including the following: Consolidated provider reporting Inventory tracking Consolidated claim editing and messaging The Switch also receives transactions from providers and intermediaries as claims pass from providers to adjudicators. Switching companies accept transactions, optionally perform format conversions, and optionally perform pre-edits or post-edits., The switch passes the transaction to the appropriate processor. The reply from the processor also may pass through the switch on its return to the provider. (In some instances the switch returns an approved response if the transaction is for a cash prescription.) Providers utilize the services of a switch for a number of reasons, including the following: Capture of data Pre and/or post editing A processor may not support Dial-Up communications All transactions can be transmitted to one central point, the Switch Increased reliability of communications 3

8

National Council for Prescription Drug Programs

National Council for Prescription Drug Programs National Council for Prescription Drug Programs White Paper The Proper Use of the NCPDP Telecommunication Standard Version D.0 as it applies to the Implementation of Medicaid Reimbursement Methodologies

More information

Upstream Reporting of Copay Assistance Issues Brief

Upstream Reporting of Copay Assistance Issues Brief Upstream Reporting of Copay Assistance Issues Brief National Council for Prescription Drug Programs 9240 East Raintree Drive Scottsdale, AZ 85260 Phone: (480) 477-1000 Fax: (480) 767-1042 e-mail: ncpdp@ncpdp.org

More information

emedny Prospective Drug Utilization Review/ Electronic Claim Capture and Adjudication ProDUR/ECCA Standards

emedny Prospective Drug Utilization Review/ Electronic Claim Capture and Adjudication ProDUR/ECCA Standards STATE OF NEW YORK DEPARTMENT OF HEALTH emedny Prospective Drug Utilization Review/ Electronic Claim Capture and Adjudication ProDUR/ECCA Standards December 18, 2003 Version 1.7 December 2003 Computer Sciences

More information

emedny Prospective Drug Utilization Review/ Electronic Claim Capture and Adjudication ProDUR/ECCA Standards

emedny Prospective Drug Utilization Review/ Electronic Claim Capture and Adjudication ProDUR/ECCA Standards STATE OF NEW YORK DEPARTMENT OF HEALTH emedny Prospective Drug Utilization Review/ Electronic Claim Capture and Adjudication ProDUR/ECCA Standards December 06, 2005 Version 1.18 December 2005 Computer

More information

emedny Prospective Drug Utilization Review/ Electronic Claim Capture and Adjudication ProDUR/ECCA Standards

emedny Prospective Drug Utilization Review/ Electronic Claim Capture and Adjudication ProDUR/ECCA Standards STATE OF NEW YORK DEPARTMENT OF HEALTH emedny Prospective Drug Utilization Review/ Electronic Claim Capture and Adjudication ProDUR/ECCA Standards July 30, 2010 Version 1.33 July 2010 Computer Sciences

More information

NCPDP Electronic Prescribing Standards

NCPDP Electronic Prescribing Standards NCPDP Electronic Prescribing Standards May 2014 1 What is NCPDP? An ANSI-accredited standards development organization. Provides a forum and marketplace for a diverse membership focused on health care

More information

X12N/005010X220A1Benefit Enrollment and Maintenance (834) and the X12N/005010X221A1 Health Care Claim Payment/Advice (835) QUESTIONS AND ANSWERS

X12N/005010X220A1Benefit Enrollment and Maintenance (834) and the X12N/005010X221A1 Health Care Claim Payment/Advice (835) QUESTIONS AND ANSWERS X12N/005010X220A1Benefit Enrollment and Maintenance (834) and the X12N/005010X221A1 Health Care Claim Payment/Advice (835) QUESTIONS AND ANSWERS Version 1.2 March 2017 National Council for Prescription

More information

Texas Vendor Drug Program Pharmacy Provider Procedure Manual

Texas Vendor Drug Program Pharmacy Provider Procedure Manual Texas Vendor Drug Program Pharmacy Provider Procedure Manual System Requirements May 2018 The Pharmacy Provider Procedure Manual (PPPM) is available online at txvendordrug.com/about/policy/manual. ` Table

More information

2019 Transition Policy

2019 Transition Policy 2019 Number: 5.8 Prescription Drug Replaces: 5.8 v.2018 Cross 5.1.2 Transition Fill Monitoring Procedure References: Purpose: To provide guidance on the transition process for new or current Plan members

More information

Subject: Indiana Health Coverage Programs (IHCP) Transition to the National Council for Prescription Drug Programs (NCPDP) Version 5.

Subject: Indiana Health Coverage Programs (IHCP) Transition to the National Council for Prescription Drug Programs (NCPDP) Version 5. P R O V I D E R B U L L E T I N B T 2 0 0 3 6 1 S E P T E M B E R 1 9, 2 0 0 3 To: All Pharmacy Providers Subject: Indiana Health Coverage Programs (IHCP) Transition to the National Council for Prescription

More information

Pennsylvania PROMISe Companion Guide

Pennsylvania PROMISe Companion Guide Pennsylvania PROMISe Companion Guide NCPDP Version D.0 September 2010 Version 1.0 This page is left intentionally blank September 2010 Table of Contents Overview... 1 Revisions to the Companion Guide...

More information

E-PRESCRIBING SERVICES TERMS

E-PRESCRIBING SERVICES TERMS E-PRESCRIBING SERVICES TERMS Certain software licensed by Allscripts Healthcare, LLC ( Allscripts ) may allow Client to access E- Prescribing Services (as defined below) to route prescriptions, access

More information

Life Journey of a Claim

Life Journey of a Claim Full Cycle of the Argus System At the Doctor s Office To the Pharmacy At the Pharmacy Entering the Claim The doctor prescribes medication for the patient. Life Journey of a Claim The doctor writes a prescription

More information

Best Practice Recommendation for

Best Practice Recommendation for Best Practice Recommendation for Exchanging & Processing about Pharmacy Benefit Management Version 020915a Issue Date Version Explanation 10-20-2014 First Release 02-09-15 Clarify language under Health

More information

Harvard Pilgrim Health Care Pharmacy Services Policy & Criteria. Medicare Advantage Transition of Care

Harvard Pilgrim Health Care Pharmacy Services Policy & Criteria. Medicare Advantage Transition of Care SCOPE: Harvard Pilgrim Health Care Medicare Advantage enrollees, their providers, and all HPHC Pharmacy, Customer Service and Appeals & Grievances Staff. OBJECTIVE: To efficiently provide new enrollees

More information

Magellan Complete Care of Virginia (MCC of VA) Provider Training. July 2017

Magellan Complete Care of Virginia (MCC of VA) Provider Training. July 2017 Magellan Complete Care of Virginia (MCC of VA) Provider Training July 2017 A Managed Long Term Services and Supports Program On August 1, 2017, Magellan Complete Care of Virginia (MCC of VA) part of the

More information

2012 Checklist for Community Pharmacy. Medicare Part D-Related Information

2012 Checklist for Community Pharmacy. Medicare Part D-Related Information NATIONAL COMMUNITY PHARMACISTS ASSOCIATION 2012 Checklist for Community Pharmacy Medicare Part D-Related Information Medicare Part D Valid Prescriber Identifiers For 2012, CMS will continue to permit the

More information

NCPDP VERSION 5.1 REQUEST PAYER SHEET

NCPDP VERSION 5.1 REQUEST PAYER SHEET NCPDP VERSION 5.1 REQUEST PAYER SHEET Payer Name: WellPoint Pharmacy Revised Date: 12/11/2005 Management Processor: WellPoint Pharmacy Switch: All Management Effective as of: 1/1/2006 Version/Release #:

More information

Harvard Pilgrim Health Care Pharmacy Services Policy & Criteria. Medicare Advantage Transition of Care

Harvard Pilgrim Health Care Pharmacy Services Policy & Criteria. Medicare Advantage Transition of Care SCOPE: Medicare Advantage enrollees, their providers, and all HPHC Pharmacy, Customer Service and Appeals & Grievances Staff. OBJECTIVE: To avoid interruption in therapy, timely access to a temporary supply

More information

NCPDP EMERGENCY PREPAREDNESS INFORMATION

NCPDP EMERGENCY PREPAREDNESS INFORMATION NCPDP EMERGENCY PREPAREDNESS INFORMATION VERSION 1.4 This document provides resource information for the pharmacy industry for a declared emergency. National Council for Prescription Drug Programs 9240

More information

Martin s Point Generations Advantage Policy and Procedure Form

Martin s Point Generations Advantage Policy and Procedure Form Martin s Point Generations Advantage Policy and Procedure Form Policy #: PartD.923 Effective Date: 4/16/10 Policy Title: Part D Transition Policy Section of Manual: Medicare Prescription Drug Benefit Manual

More information

Community Care, Inc. Medicare Part-D Enrollee Transition Plans H5212 PACE and H2034 HMO-SNP 2018

Community Care, Inc. Medicare Part-D Enrollee Transition Plans H5212 PACE and H2034 HMO-SNP 2018 Title: and H2034 HMO-SNP 2018 Policy Identifier: PA - Pharmacy Effective Date: 20180101 Scope: Organization Wide Family Care PACE Partnership Waukesha Day Center HUD (Housing and Urban Development) Department:

More information

CHIPS Rules and Administrative Procedures Effective January 1, 2018

CHIPS Rules and Administrative Procedures Effective January 1, 2018 CHIPS Rules and Administrative Procedures Effective January 1, 2018 Copyright 2017 by The Clearing House Payments Company L.L.C. All rights reserved. RULES GOVERNING THE CLEARING HOUSE INTERBANK PAYMENTS

More information

Information Maintained by the Office of Code Revision Indiana Legislative Services Agency IC Chapter 22. Pharmacy Audits

Information Maintained by the Office of Code Revision Indiana Legislative Services Agency IC Chapter 22. Pharmacy Audits Information Maintained by the Office of Code Revision Indiana Legislative Services Agency IC 25-26-22 Chapter 22. Pharmacy Audits IC 25-26-22-1 Definitions applicable to chapter Sec. 1. The definitions

More information

Medicare Transition POLICY AND PROCEDURES

Medicare Transition POLICY AND PROCEDURES Medicare Transition POLICY AND PROCEDURES POLICY The Plan will maintain an appropriate transition process, consistent with 42 CFR 423.120(b)(3), Chapter 6 of the Medicare Prescription Drug Benefit Manual

More information

NCPDP Version 5 Request Payer Sheet

NCPDP Version 5 Request Payer Sheet NCPDP Version 5 Request Payer Sheet NCPDP Rev.04.16.02 General Information Payer Name: 4-D Pharmacy Benefits Plan Name/Group Name: 4-D Pharmacy Benefits Processor: Argus Payer Sheet Revision Effective

More information

WELCOME TO OUR OFFICE. Patient s Name: Today s Date: First Middle Last. Home Address: City: State: Zip: Telephone: Home ( ) Cellular: ( ) Work: ( )

WELCOME TO OUR OFFICE. Patient s Name: Today s Date: First Middle Last. Home Address: City: State: Zip: Telephone: Home ( ) Cellular: ( ) Work: ( ) WELCOME TO OUR OFFICE Patient s Name: Today s Date: First Middle Last Home Address: City: State: Zip: Telephone: Home ( ) Cellular: ( ) Work: ( ) Email: Personal Work DOB: Age: SSN#: Ethnic Background:

More information

NCPDP Update. Review of NCPDP Task Group Efforts and Use Cases for Real-Time Benefit Inquiry Standard. May 23, 2017

NCPDP Update. Review of NCPDP Task Group Efforts and Use Cases for Real-Time Benefit Inquiry Standard. May 23, 2017 NCPDP Update Review of NCPDP Task Group Efforts and Use Cases for Real-Time Benefit Inquiry Standard May 23, 2017 Catherine C Graeff CEO, Sonora Advisory Group, LLC Active in NCPDP since 1988 - as a member,

More information

2019 Transition Policy and Procedure

2019 Transition Policy and Procedure 2019 Transition Policy and Procedure POLICY Steward Health Choice Generations (SHCG) provides a Part D drug transition process in order to prevent enrollee medication coverage gaps. SHCG s transition process

More information

What Regulatory Requirements are Responsible for the Transactions Standards?

What Regulatory Requirements are Responsible for the Transactions Standards? Versions 5010 Why the Change? 99% of Medicare Part A and 96% of Part B Claims are submitted electronically New Accreditations standards adopted with Electronic Medical Records must align with the submitted

More information

Enrollment Form for ENTRESTO Central Patient Support Program

Enrollment Form for ENTRESTO Central Patient Support Program Enrollment Form for ENTRESTO Central Patient Support Program Dear Health Care Professional, Thank you for choosing ENTRESTO Central Patient Support Program. Please take a moment to read through the instructions

More information

PURPOSE OF THE POLICY STATEMENT OF THE POLICY PROCEDURES

PURPOSE OF THE POLICY STATEMENT OF THE POLICY PROCEDURES PURPOSE OF THE POLICY The purpose of this policy is to describe Health Alliance s process for transitions and ensure that continued drug coverage is provided to new and current Part D members. The transition

More information

Indiana Health Coverage Program Seminar Presented by MDwise Pharmacy October 22-24, 2007 P0153 (9/07)

Indiana Health Coverage Program Seminar Presented by MDwise Pharmacy October 22-24, 2007 P0153 (9/07) Indiana Health Coverage Program Seminar Presented by MDwise Pharmacy October 22-24, 2007 P0153 (9/07) Overview Pharmacy Benefit Manager Pharmacy Claims Processor Preferred Drug List Pharmacist Override

More information

OTHER TRANSACTIONS SUPPORTED Payer: Please list each transaction supported with the segments, fields, and pertinent information on each transaction.

OTHER TRANSACTIONS SUPPORTED Payer: Please list each transaction supported with the segments, fields, and pertinent information on each transaction. NCPDP VERSION D CLAIM BILLING/CLAIM REBILL REQUEST CLAIM BILLING/CLAIM REBILL PAYER SHEET ** Start of Request (B1/B3) Payer Sheet ** GENERAL INFORMATION Payer Name: AmeriHealth Caritas Louisiana Date:

More information

OTHER TRANSACTIONS SUPPORTED Payer: Please list each transaction supported with the segments, fields, and pertinent information on each transaction.

OTHER TRANSACTIONS SUPPORTED Payer: Please list each transaction supported with the segments, fields, and pertinent information on each transaction. NCPDP VERSION D CLAIM BILLING/CLAIM REBILL REQUEST CLAIM BILLING/CLAIM REBILL PAYER SHEET ** Start of Request (B1/B3) Payer Sheet ** GENERAL INFORMATION Payer Name: Community Health Choices Date: 09/21/2017

More information

K A R A N J O HA R, M.D.

K A R A N J O HA R, M.D. P: : REGISTRATION FORM - MAJOR MEDICAL Last Name: First and Middle Name: Social Security #: Birthdate: Age: Sex: F M Marital Status: M S D W Home Address: City: State: Zip: *Does the above address, match

More information

Integrated Prescription Management (IPM)/ PharmAvail Benefit Management Payor Specification Sheet

Integrated Prescription Management (IPM)/ PharmAvail Benefit Management Payor Specification Sheet Integrated Prescription anagement (IP)/ PharmAvail Benefit anagement Payor Specification Sheet BIN #: 014658, 610114 Effective Date: 03/01/2011 States: National Destination: Integrated Prescription anagement

More information

Elite Visa Benefit Card Frequently Asked Questions

Elite Visa Benefit Card Frequently Asked Questions What is the Elite Visa Benefit Card? The Elite Benefit Card is a stored-value card that simplifies the process of paying for qualified health flexible spending account (FSA) expenses. As an alternative

More information

**** Does the above address, match the address on your State Identification Card? Yes No *****

**** Does the above address, match the address on your State Identification Card? Yes No ***** Kenneth B. Chapman, M.D. Kiran V. Patel, M.D. Keyvan Jahanbakhsh, M.D. Uel J. Alexis, M.D. Cameron Marshall, M.D. Brian Maloney, M.D. Last Name First Name: SS# Birth : / / Age Sex: F M Marital Status:

More information

Re: Modernizing Part D and Medicare Advantage to Lower Drug Prices and Reduce Out-of- Pocket Expenses [CMS-4180-P]

Re: Modernizing Part D and Medicare Advantage to Lower Drug Prices and Reduce Out-of- Pocket Expenses [CMS-4180-P] January 25, 2019 Seema Verma, Administrator Centers for Medicare & Medicaid Services Department of Health and Human Services Attention: CMS-4180-P P.O. Box 8013 Baltimore, MD 21244-8013 Re: Modernizing

More information

NCPA summary of Part D Final Rule for contract year NCPA advocacy at work

NCPA summary of Part D Final Rule for contract year NCPA advocacy at work NCPA summary of Part D Final Rule for contract year 2019 The Centers for Medicare and Medicaid Services ( CMS ) recently issued its final rule (the Final Rule ) to revise the Medicare Advantage and Part

More information

Claim Revenue Optimization- Atlantic

Claim Revenue Optimization- Atlantic ................................................................................................... Claim Revenue Optimization- Atlantic Pharmacy Technology Solutions April, 2014 Modify a Prescription

More information

Real-Time Pharmacy Benefit Inquiry: The Time is Right for More Informed Medication Decisions

Real-Time Pharmacy Benefit Inquiry: The Time is Right for More Informed Medication Decisions Real-Time Pharmacy Benefit Inquiry: The Time is Right for More Informed Medication Decisions PBMI Annual Drug Benefit Conference March 6, 2017 PRESENTERS: Anthony Schueth, Point-of-Care Partners Julia

More information

Payer Specification Sheet For Prime Therapeutics BCBS of Texas CHIP, STAR and STAR KIDS Medicaid Programs

Payer Specification Sheet For Prime Therapeutics BCBS of Texas CHIP, STAR and STAR KIDS Medicaid Programs Payer Specification Sheet For Prime Therapeutics BCBS of Texas CHIP, STAR and STAR KIDS Medicaid Programs General information Prime Therapeutics LLC September 1, 2018 Plan Name BIN PCN BCBS of Texas Medicaid

More information

Claim Revenue Optimization - Ontario

Claim Revenue Optimization - Ontario ................................................................................................... Claim Revenue Optimization - Ontario Pharmacy Technology Solutions January, 2015 Modify a Prescription

More information

Medicare Part D Transition Policy

Medicare Part D Transition Policy Medicare Part D Transition Policy Transition Policy for New and Current Enrollees of our Medicare Part D Prescription Drug Plan PURPOSE: Simply Healthcare Plans, Inc. must maintain an appropriate transition

More information

TELECOMMUNICATION VERSION 5 QUESTIONS, ANSWERS AND EDITORIAL UPDATES

TELECOMMUNICATION VERSION 5 QUESTIONS, ANSWERS AND EDITORIAL UPDATES TELECOMMUNICATION VERSION 5 QUESTIONS, ANSWERS AND EDITORIAL UPDATES DOCUMENTATION November 2Ø1Ø National Council for Prescription Drug Programs 924Ø East Raintree Drive Scottsdale, AZ 8526Ø Phone: (48Ø)

More information

I. PURPOSE. A. The primary objectives of Molina Healthcare s Transition Policy and Procedure are:

I. PURPOSE. A. The primary objectives of Molina Healthcare s Transition Policy and Procedure are: I. PURPOSE The purpose of the Policy and Procedure is to ensure necessary continuity of treatment and to provide adequate time and transition process to introduce the enrollee and their prescribing physician

More information

TELECOMMUNICATION VERSION D AND ABOVE QUESTIONS, ANSWERS AND EDITORIAL UPDATES

TELECOMMUNICATION VERSION D AND ABOVE QUESTIONS, ANSWERS AND EDITORIAL UPDATES TELECOMMUNICATION VERSION D AND ABOVE QUESTIONS, ANSWERS AND EDITORIAL UPDATES DOCUMENTATION National Council for Prescription Drug Programs 924Ø East Raintree Drive Scottsdale, AZ 8526Ø Phone: (48Ø) 477-1ØØØ

More information

The Health Insurance Portability and Accountability Act of 1996 (HIPAA) and the Pharmacy Benefit: Implications for Health Plans, PBMs, and Providers

The Health Insurance Portability and Accountability Act of 1996 (HIPAA) and the Pharmacy Benefit: Implications for Health Plans, PBMs, and Providers CONTEMPORARY SUBJECT The Health Insurance Portability and Accountability Act of 1996 (HIPAA) and the Pharmacy Benefit: Implications for Health Plans, PBMs, and Providers DANIEL C. WALDEN, JD, and ROBERT

More information

Dr. Sarah Y. Vinson s Practice Policies

Dr. Sarah Y. Vinson s Practice Policies Dr. Sarah Y. Vinson s Practice Policies FEE SCHEDULE: $230 50 minute psychotherapy and/or psychopharmacology appt. $450 2 hour initial intake appt. $155 30 minute phone, Skype or in-person appt.; $125

More information

Frequently Asked Questions by Plan Members Who Require Special Authorization for Their Drugs

Frequently Asked Questions by Plan Members Who Require Special Authorization for Their Drugs Frequently Asked Questions by Plan Members Who Require Special Authorization for Their Drugs 1. What is Special Authorization (SA)? Your drug plan may designate a drug as Special Authorization (SA) Required.

More information

Ch. 358, Art. 4 LAWS of MINNESOTA for

Ch. 358, Art. 4 LAWS of MINNESOTA for Ch. 358, Art. 4 LAWS of MINNESOTA for 2008 14 paragraphs (c) and (d), whichever is later. The commissioner of human services shall notify the revisor of statutes when federal approval is obtained. ARTICLE

More information

Pharmacy Provider Enrollment Application

Pharmacy Provider Enrollment Application 1. Application Date 11/28/2018 New Pharmacy Re-enrollment Vendor # 2. Applicant Name Of Pharmacy (Doing Business As) ABC Pharmacy Legal contractor name ABC Pharmacy, Inc Telephone Fax Email Change of Ownership

More information

2012 Medicare Part D Transition Process for contracts H3864 & H4754:

2012 Medicare Part D Transition Process for contracts H3864 & H4754: 2012 Medicare Part D Transition Process for contracts H3864 & H4754: Essentials Rx 6, Essentials Rx 14, Essentials Rx 15, Essentials Rx 16, Premier Rx 7, Explorer Rx 1, Explorer Rx 2, and Explorer Rx 4

More information

All Pharmacy Providers and Prescribing Practitioners. Subject: Significant Changes to Pharmacy Claims Processing

All Pharmacy Providers and Prescribing Practitioners. Subject: Significant Changes to Pharmacy Claims Processing P R O V I D E R B U L L E T I N BT200260 NOVEMBER 18, 2002 To: All Pharmacy Providers and Prescribing Practitioners Subject: Significant Changes to Pharmacy Claims Processing Note: The information in this

More information

2015 PacificSource Medicare Part D Transition Process for contracts H3864 & H4754:

2015 PacificSource Medicare Part D Transition Process for contracts H3864 & H4754: 2015 PacificSource Medicare Part D Transition Process for contracts H3864 & H4754: Essentials Rx 6 (HMO), Essentials Rx 14 (HMO), Essentials Rx 15 (HMO), Essentials Rx 16 (HMO), Essentials Rx 19 (HMO),

More information

Electronic Prior Authorization Initiatives at the Point of Care: Moving the Industry Forward

Electronic Prior Authorization Initiatives at the Point of Care: Moving the Industry Forward Electronic Prior Authorization Initiatives at the Point of Care: Moving the Industry Forward Friday, April 20 th from 11:45am to 12:45am Marc Nyarko, Humana Bruce Wilkinson, CVS Caremark Roger Pinsonneault,

More information

emedny New York State Department of Health Office of Health Insurance Programs Pended Claims Report:

emedny New York State Department of Health Office of Health Insurance Programs Pended Claims Report: emedny New York State Department of Health Office of Health Insurance Programs Pended Claims Report: Specification Version: 1.2 Publication: 10/26/2016 Trading Partner: emedny NYSDOH 1 emedny Pended Claims

More information

Braeburn Patient Assistance Program Application

Braeburn Patient Assistance Program Application The provides Probuphine at no cost to patients that do not have healthcare coverage and/or adequate coverage for Probuphine. All applications are reviewed on a case-by-case basis to support the Braeburn

More information

Formulary Services EULA

Formulary Services EULA Formulary Services EULA Formulary Services. Allscripts is reliant on Surescripts in facilitating the provision of the Formulary Services described in Schedule A (the Formulary Services Terms ). If Surescripts

More information

2018 Transition Fill Policy & Procedure. Policy Title: Issue Day: Effective Dates: 01/01/2018

2018 Transition Fill Policy & Procedure. Policy Title: Issue Day: Effective Dates: 01/01/2018 Policy Title: Department: Policy Number: 2018 Transition Fill Policy & Procedure Pharmacy CH-MCR-PH-01 Issue Day: Effective Dates: 01/01/2018 Next Review Date: 04/01/2018 Revision Dates: 05/19/2016 11/14/2016

More information

HOW TO REGISTER ON THE OECD ESOURCING PORTAL

HOW TO REGISTER ON THE OECD ESOURCING PORTAL HOW TO REGISTER ON THE OECD ESOURCING PORTAL Bidder - User Guide OECD all rights reserved Create your Organisation Profile Access the esourcing Portal following the link: https://oecd.bravosolution.com

More information

Supplemental Payer Transactions (Nx) Part D Plan Nx Performance Reports Guide Effective

Supplemental Payer Transactions (Nx) Part D Plan Nx Performance Reports Guide Effective Supplemental Payer Transactions (Nx) Part D Plan Nx Performance Reports Guide Effective 10-1-2017 Date: 03/09/2017 Table of Contents 1 BACKGROUND... 1 2 PURPOSE... 2 3 REPORT NAME & PURPOSE... 2 4 REPORT

More information

OTHER TRANSACTIONS SUPPORTED Payer: Please list each transaction supported with the segments, fields, and pertinent information on each transaction.

OTHER TRANSACTIONS SUPPORTED Payer: Please list each transaction supported with the segments, fields, and pertinent information on each transaction. NCPDP VERSION D CLAIM BILLING/CLAIM REBILL REQUEST CLAIM BILLING/CLAIM REBILL PAYER SHEET ** Start of Request (B1/B3) Payer Sheet ** GENERAL INFORMATION Payer Name: San Francisco Health Plan Date: 04/16/2013

More information

ANTI-FRAUD PLAN INTRODUCTION

ANTI-FRAUD PLAN INTRODUCTION ANTI-FRAUD PLAN INTRODUCTION We recognize the importance of preventing, detecting and investigating fraud, abuse and waste, and are committed to protecting and preserving the integrity and availability

More information

CHAPTER 58-29E PHARMACY BENEFITS MANAGEMENT

CHAPTER 58-29E PHARMACY BENEFITS MANAGEMENT CHAPTER 58-29E PHARMACY BENEFITS MANAGEMENT 58-29E-1. Definition of terms. Terms used in this chapter mean: (1) "Covered entity," a nonprofit hospital or medical service corporation, health insurer, health

More information

Step 3: To assist us in determining the available list of pharmacy plans to be contracted, please complete the enclosed Insurance Payer List.

Step 3: To assist us in determining the available list of pharmacy plans to be contracted, please complete the enclosed Insurance Payer List. BillingScripts Rx Initial Enrollment Packet Thank you for choosing BillingScripts Rx for your pharmaceutical billing and funding services. This Initial Enrollment Packet contains instructions and forms

More information

Prescription Drug Event (PDE) Data: Source and Processing

Prescription Drug Event (PDE) Data: Source and Processing Prescription Drug Event (PDE) Data: Source and Processing Barbara Frank, M.S., M.P.H. Director of Workshops, Outreach, & Research University of Minnesota Frequently Repeated Acronyms CMS Centers for Medicare

More information

PEP-Portland Clinical Practices Policy Number: CP Policy Owner: Health Plan Operations Manager New Revised Reviewed

PEP-Portland Clinical Practices Policy Number: CP Policy Owner: Health Plan Operations Manager New Revised Reviewed Subject: Transition Process for Medicare Part D Approval Group: Pharmacy Management Group Signed By: Ellen Garcia, Executive Director Policy Number: CP5500.120 Policy Owner: Health Plan Operations Manager

More information

Prior Authorization between Prescribers and Processors for the Pharmacy Benefit

Prior Authorization between Prescribers and Processors for the Pharmacy Benefit Prior Authorization between Prescribers and Processors for the Pharmacy Benefit Tony Schueth Lynne Gilbertson Panel 4 February 19, 2014 Electronic Prior Authorization Process for the Pharmacy Benefit using

More information

Archived SECTION 17 - CLAIMS DISPOSITION. Section 17 - Claims Disposition

Archived SECTION 17 - CLAIMS DISPOSITION. Section 17 - Claims Disposition SECTION 17 - CLAIMS DISPOSITION 17.1 ACCESS TO REMITTANCE ADVICES...2 17.2 INTERNET AUTHORIZATION...3 17.3 ON-LINE HELP...3 17.4 REMITTANCE ADVICE...3 17.5 CLAIM STATUS MESSAGE CODES...7 17.5.A FREQUENTLY

More information

STATE OF NEW JERSEY. SENATE, No th LEGISLATURE. Sponsored by: Senator NIA H. GILL District 34 (Essex and Passaic)

STATE OF NEW JERSEY. SENATE, No th LEGISLATURE. Sponsored by: Senator NIA H. GILL District 34 (Essex and Passaic) SENATE, No. STATE OF NEW JERSEY th LEGISLATURE INTRODUCED FEBRUARY, 00 Sponsored by: Senator NIA H. GILL District (Essex and Passaic) SYNOPSIS Regulates pharmacy benefits management companies. CURRENT

More information

Pharmacy Billing and Reimbursement

Pharmacy Billing and Reimbursement FSHP Disclosure Pharmacy Billing and Tara L McNulty RPhT, CPhT I, Tara McNulty, do not have a vested interest in or affiliation with any corporate organization offering financial support or grant monies

More information

emedny Prospective Drug Utilization Review/ Electronic Claims Capture and Adjudication ProDUR/ECCA Provider Manual

emedny Prospective Drug Utilization Review/ Electronic Claims Capture and Adjudication ProDUR/ECCA Provider Manual STATE OF NEW YORK DEPARTMENT OF HEALTH emedny Prospective Drug Utilization Review/ Electronic Claims Capture and Adjudication ProDUR/ECCA Provider Manual May 16, 2007 Version 1.21 May 2007 Computer Sciences

More information

AonLine Service Agreement Effective July 19, By logging into AonLine, user agrees to these terms and conditions (T&C):

AonLine Service Agreement Effective July 19, By logging into AonLine, user agrees to these terms and conditions (T&C): AonLine Service Agreement Effective July 19, 2014 By logging into AonLine, user agrees to these terms and conditions (T&C): 1. Definitions. For purposes of this Agreement, the following definitions shall

More information

Assure Card Deferred Reimbursement. Making the most of your benefits for plan members and their dependants

Assure Card Deferred Reimbursement. Making the most of your benefits for plan members and their dependants Assure Card Deferred Reimbursement Making the most of your benefits for plan members and their dependants Welcome to Assure Paying for your prescriptions has never been so easy The Assure Card Deferred

More information

PBM MODEL A A MODEL ACT RELATING TO PHARMACY BENEFIT MANAGERS*

PBM MODEL A A MODEL ACT RELATING TO PHARMACY BENEFIT MANAGERS* PBM MODEL A A MODEL ACT RELATING TO PHARMACY BENEFIT MANAGERS* Whereas: It is essential to understand the drivers and impacts of prescription drug costs, and transparency is the first step toward that

More information

Compensation and Reimbursement

Compensation and Reimbursement 492 Pharmacy Management: Compensation and Reimbursement Positions Compensation and Reimbursement Revenue Cycle Compliance and Management (1710) To encourage pharmacists to serve as leaders in the development

More information

HIPAA Implementation: The Case for a Rational Roll-Out Plan. Released: July 19, 2004

HIPAA Implementation: The Case for a Rational Roll-Out Plan. Released: July 19, 2004 HIPAA Implementation: The Case for a Rational Roll-Out Plan Released: July 19, 2004 1 1. Summary HIPAA Administrative Simplification, as it is currently being implemented, is increasing complexity and

More information

80th OREGON LEGISLATIVE ASSEMBLY Regular Session. Senate Bill 572

80th OREGON LEGISLATIVE ASSEMBLY Regular Session. Senate Bill 572 0th OREGON LEGISLATIVE ASSEMBLY--0 Regular Session Senate Bill Sponsored by Senator HANSELL, Representative SMITH G; Senator LINTHICUM (at the request of Oregon State Pharmacy Coalition) (Presession filed.)

More information

1 SB By Senators Beasley, Smitherman, Irons, Bussman and Ross. 4 RFD: Health. 5 First Read: 12-APR-11. Page 0

1 SB By Senators Beasley, Smitherman, Irons, Bussman and Ross. 4 RFD: Health. 5 First Read: 12-APR-11. Page 0 1 SB390 2 124198-2 3 By Senators Beasley, Smitherman, Irons, Bussman and Ross 4 RFD: Health 5 First Read: 12-APR-11 Page 0 1 124198-2:n:03/21/2011:MCS/ll LRS2010-4156R1 2 3 4 5 6 7 8 SYNOPSIS: Existing

More information

NCPDP VERSION D CLAIM BILLING

NCPDP VERSION D CLAIM BILLING NCPDP VERSION D CLAI BILLING REQUEST CLAI BILLING SECONDARY PAYER IS EDICARE D BASED ON OTHER PAYER PAID PAYER SHEET GENERAL INFORATION Payer Name: Envolve Pharmacy Solutions Date: Plan Name/Group Name:

More information

Employers Forum of Indiana and epa. March 23, 2016

Employers Forum of Indiana and epa. March 23, 2016 Employers Forum of Indiana and epa March 23, 2016 Copyright Copyright 2016 by 2016 Surescripts, by Surescripts, LLC. All LLC. rights All reserved. rights reserved. Prior authorization, the problem we are

More information

LEGISLATURE 2017 BILL. reporting by manufacturers and providing a penalty.

LEGISLATURE 2017 BILL. reporting by manufacturers and providing a penalty. 0-0 LEGISLATURE LRB-/ 0 AN ACT to create.0 of the statutes; relating to: prescription drug cost reporting by manufacturers and providing a penalty. Analysis by the Legislative Reference Bureau This bill

More information

Insightsfeature. Managing Specialty Drug Spend Under the Medical Benefit. Innovations and Automation for More Effective Management.

Insightsfeature. Managing Specialty Drug Spend Under the Medical Benefit. Innovations and Automation for More Effective Management. Insightsfeature Managing Specialty Drug Spend Under the Medical Benefit Innovations and Automation for More Effective Management March 30, 2017 The Less-Visible Part of Specialty Spend By most estimates,

More information

1 INSURANCE SECTION Instructions: This section contains information about the cardholder and their plan identification.

1 INSURANCE SECTION Instructions: This section contains information about the cardholder and their plan identification. 1 INSURANCE SECTION : This section contains information about the cardholder and their plan identification. 1 ID of Cardholder Required. Enter the recipient s 13 digit Medicaid ID. 2 Group ID Not Required.

More information

Renee Gravalin, Partner

Renee Gravalin, Partner Experience the Eide Bailly Difference 340B Drug Program Renee Gravalin, Partner rgravalin@eidebailly.com 701.799.5449 Agenda Proposed Changes 1 Experience the Eide Bailly Difference Created in 1992 to

More information

DEMOGRAPHICS & BILLING INFORMATION

DEMOGRAPHICS & BILLING INFORMATION Jeffrey B. Russell, MD, FACOG, Director Board Certified Reproductive Endocrinology & Infertility 4745 Ogletown-Stanton Road Suite 111 Newark, DE 19713 Tel: 302-738-4600 Fax: 302-738-3508 556 South DuPont

More information

Braeburn Access Program Probuphine (buprenorphine) Implant Patient Buy and Bill Order Form

Braeburn Access Program Probuphine (buprenorphine) Implant Patient Buy and Bill Order Form Braeburn Access Program Probuphine (buprenorphine) Implant Patient Buy and Bill Order Form Section 1: Patient Information Please complete all fields on the form and fax to 1-866-441-4091 or email info@braeburnaccessprogram.com

More information

340B Drug Program Compliance: Focus on Disproportionate Hospitals

340B Drug Program Compliance: Focus on Disproportionate Hospitals 340B Drug Program Compliance: Focus on Disproportionate Hospitals Part II: 340B Drug Program Compliance: Pharmacy Operations and the DSH January 29, 2014 1 Faculty Stephen J. Weiser, JD, LLM Director 312-403-4284

More information

Texas Vendor Drug Program. Pharmacy Provider Procedure Manual Coordination of Benefits. Effective Date. February 2018

Texas Vendor Drug Program. Pharmacy Provider Procedure Manual Coordination of Benefits. Effective Date. February 2018 Texas Vendor Drug Program Pharmacy Provider Procedure Manual Coordination of Benefits Effective Date February 2018 The Pharmacy Provider Procedure Manual (PPPM) is available online at txvendordrug.com/about/policy/manual.

More information

PATIENT REGISTRATION FORM

PATIENT REGISTRATION FORM Today s Date / / PATIENT REGISTRATION FORM PATIENT INFORMATION Patient Name Last First Middle Is this your legal name? If not, what is your legal name? Birthdate Age Sex q YES q NO / / q M q F q T Street

More information

2018 Medicare Part D Transition Policy

2018 Medicare Part D Transition Policy Regulation/ Requirements Purpose Scope Policy 2018 Medicare Part D Transition Policy 42 CFR 423.120(b)(3) 42 CFR 423.154(a)(1)(i) 42 CFR 423.578(b) Medicare Prescription Drug Benefit Manual, Chapter 6,

More information

GERALD (JERRY) LEWANDOWSKI. BERKELEY RESEARCH GROUP, LLC 1800 M Street NW, Second Floor Washington, DC 20036

GERALD (JERRY) LEWANDOWSKI. BERKELEY RESEARCH GROUP, LLC 1800 M Street NW, Second Floor Washington, DC 20036 Curriculum Vitae GERALD (JERRY) LEWANDOWSKI BERKELEY RESEARCH GROUP, LLC 1800 M Street NW, Second Floor Washington, DC 20036 Direct: 202.480.2643 Mobile: 202.258.2669 jlewandowski@thinkbrg.com Jerry Lewandowski

More information

IEHP Medicare DualChoice Program Pharmacy Program Manual

IEHP Medicare DualChoice Program Pharmacy Program Manual IEHP Medicare DualChoice Program Pharmacy Program Manual Claim processing information Patient Location Code: Please enter the appropriate Patient Location Code for each claim. Incorrect patient location

More information

Christina Agustin, MD Board Certified in Adult Psychiatry 1 Lake Bellevue Drive, Suite 101 Bellevue, WA Phone Fax:

Christina Agustin, MD Board Certified in Adult Psychiatry 1 Lake Bellevue Drive, Suite 101 Bellevue, WA Phone Fax: Christina Agustin, MD Board Certified in Adult Psychiatry 1 Lake Bellevue Drive, Suite 101 Bellevue, WA 98005 Phone 425-301-9869 Fax: 866-546-1618 Welcome to my practice. I look forward to meeting with

More information

Arizona Department of Health Services Division of Behavioral Health Services PROVIDER MANUAL NARBHA Edition

Arizona Department of Health Services Division of Behavioral Health Services PROVIDER MANUAL NARBHA Edition Arizona Department of Health Services Division of Behavioral Health Services PROVIDER MANUAL NARBHA Edition Section 6.2 6.2.1 Introduction 6.2.2 References 6.2.3 Scope 6.2.4 Did you know? 6.2.5 Definitions

More information

UNIVERSITY - INDUSTRY SPONSORED RESEARCH AGREEMENT

UNIVERSITY - INDUSTRY SPONSORED RESEARCH AGREEMENT UNIVERSITY - INDUSTRY SPONSORED RESEARCH AGREEMENT THIS SPONSORED RESEARCH AGREEMENT (the Agreement ), effective this day of, 20 ( Effective Date ) is made by and between Northeastern University, a non-profit

More information

SPRINT CLOUDCOMPUTE INFRASTRUCTURE SERVICES PRODUCT ANNEX

SPRINT CLOUDCOMPUTE INFRASTRUCTURE SERVICES PRODUCT ANNEX SPRINT CLOUDCOMPUTE INFRASTRUCTURE SERVICES PRODUCT ANNEX The following terms and conditions, together with the Sprint Standard Terms and Conditions for Communication Services ( Standard Terms and Conditions

More information